taking semaglutide but not losing weight on Semaglutide? Genetic & Biomarker Context – PlexusDx Stopping Semaglutide: How to Keep

The mechanisms and period of action of the various treatments are summarized in Table 3

consistent ~12-15% weight loss at 68 weeks Compound Tirzepatide (Zepbound) Class GIP/GLP-1 dual agonist FDA Status FDA-approved for chronic weight management Evidence Strength Phase 3 RCTs

GLP-1 Weight Loss Program Provider-prescribed semaglutide or tirzepatide as low as $194/mo* Full-dose GLP-1 therapy with ongoing provider support designed for meaningful, sustainable weight loss

Since retatrutide is not yet approved, its dosing protocols reflect what was studied in clinical trials, not formal prescribing guidelines

But what does a CBC show, and why is it so important